Sareum - Specialists in Cancer Drug Discovery
Print the page Smaller text Larger text

 

Sareum Admission to AIM
11 October, 2004

Board Appointments
15 September, 2004

 

Previous releases

2010 2009 2008 2007 2006 2005 2004

RSS news feed News feed
requires RSS news reader

2 September 2010

Sareum Holdings Plc

(“the Company”)

Holdings in Company

The Company announces, following notification received today, that following a sale of 7,000,000 ordinary shares in the capital of the Company (“Ordinary Shares”) on 1 September 2010, Mr and Mrs Leonard Licht hold a total of 47,500,000 Ordinary Shares, equivalent to 3.72 per cent. of the Company’s voting share capital.

Enquiries:

Sareum Holdings plc

 

Tim Mitchell

01223 497 700

Merchant Securities Limited

Simon Clements/Bidhi Bhoma

020 7628 2200

Hybridan LLP

 

Claire Noyce

020 7947 4350

 



Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader


site map

email: info@sareum.co.uk tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701